Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2064]
News [3529]
Articles [160]
Editorials [3]
Conferences [127]
elearning [18]

ABVD chemo with radiation therapy for limited-stage hodgkin lymphoma

Dr Ralph Meyer - National Cancer Institute of Canada Clinical Trials Group
ABVD chemo with radiation therapy for limited-stage hodgkin lymphoma ( Dr Ralph Meyer - National Cancer Institute of Canada Clinical Trials Group )
9 Jan 2012

Two rituximab dosing strategies for low tumour burden follicular lymphoma (RESORT)

Prof Brad Kahl - University of Wisconsin, Madison, USA
Two rituximab dosing strategies for low tumour burden follicular lymphoma (RESORT) ( Prof Brad Kahl - University of Wisconsin, Madison, USA )
9 Jan 2012

Cereblon expression required for anti-myeloma activity of lenalidomide and pomalidomide

Prof Keith Stewart - Mayo Clinic, Scottsdale, USA
Cereblon expression required for anti-myeloma activity of lenalidomide and pomalidomide ( Prof Keith Stewart - Mayo Clinic, Scottsdale, USA )
9 Jan 2012

The latest for Multiple Myeloma

Prof Paul Richardson - Dana Farber Institute, Boston, USA
The latest for Multiple Myeloma ( Prof Paul Richardson - Dana Farber Institute, Boston, USA )
19 Dec 2011

Myelodysplastic syndrome drug development and combination therapy

Prof Valeria Santini – University of Florence, Italy
Myelodysplastic syndrome drug development and combination therapy ( Prof Valeria Santini – University of Florence, Italy )
19 Dec 2011

Clinical trial data on treatment of chronic lymphocytic leukaemia with PCI-32765

Dr Susan O’Brien – MD Anderson Cancer Center, Houston, USA
Clinical trial data on treatment of chronic lymphocytic leukaemia with PCI-32765 ( Dr Susan O’Brien – MD Anderson Cancer Center, Houston, USA )
19 Dec 2011

Update and new perspectives in the management of MDS

Dr Mikkael Sekeres – Cleveland Clinic Taussig Institute, USA
Update and new perspectives in the management of MDS ( Dr Mikkael Sekeres – Cleveland Clinic Taussig Institute, USA )
19 Dec 2011

New data on aggressive B cell lymphoma

Dr Elaine Jaffe – National Cancer Institute, Bethesda, USA
New data on aggressive B cell lymphoma ( Dr Elaine Jaffe – National Cancer Institute, Bethesda, USA )
19 Dec 2011

Update on the phase III VISTA trial

Dr Jesus San Miguel – University Hospital of Salamanca, Spain
Update on the phase III VISTA trial ( Dr Jesus San Miguel – University Hospital of Salamanca, Spain )
19 Dec 2011

Update on the development of proteasome inhibitors

Dr Philip McCarthy – Roswell Park Cancer Institute, USA
Update on the development of proteasome inhibitors ( Dr Philip McCarthy – Roswell Park Cancer Institute, USA )
19 Dec 2011

Romidepsin treatment in peripheral T cell lymphoma and subsets

Dr Francine Foss – Yale School of Medicine, Connecticut, USA
Romidepsin treatment in peripheral T cell lymphoma and subsets ( Dr Francine Foss – Yale School of Medicine, Connecticut, USA )
19 Dec 2011

Optimal treatment schedule for pomalidomide in multiple myeloma

Prof Gareth Morgan, Royal Marsden Hospital, London, UK and Dr Xavier Leleu, Hôpital Huriez, CHRU Lille, France
Optimal treatment schedule for pomalidomide in multiple myeloma ( Prof Gareth Morgan, Royal Marsden Hospital, London, UK and Dr Xavier Leleu, Hôpital Huriez, CHRU Lille, France )
19 Dec 2011

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation